Endocrinology (all articles)
Guideline | Management of adrenal incidentalomas
23 Jun, 2023 | 13:33h | UTCRelated:
Investigation and assessment of adrenal incidentalomas – Clinical Medicine Journal
#377 Adrenal Incidentalomas with Dr. William Young – The Curbsiders
Cohort Study | Real-world data links valproate, antipsychotics to higher diabetes risk in bipolar disorder
23 Jun, 2023 | 13:32h | UTC
Cohort Study | Adiposity impacts cancer risk differently in males and females
22 Jun, 2023 | 15:08h | UTCAdiposity and sex-specific cancer risk – Cancer Cell
News Release: Cancer has an obesity-related risk factor, and it depends on sex and cancer type – Cell Press
SCORE2-Diabetes | 10-year cardiovascular risk estimation in type 2 diabetes in Europe
22 Jun, 2023 | 14:57h | UTC
Commentary on Twitter
SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe https://t.co/lkPTzqk0Kg @escardio #EHJ #ESCYoung pic.twitter.com/5TxesSwN1t
— European Society of Cardiology Journals (@ESC_Journals) June 14, 2023
The foot in diabetes – a reminder of an ever-present risk
21 Jun, 2023 | 13:10h | UTCThe foot in diabetes – a reminder of an ever-present risk – Clinical Medicine Journal
Related: Guideline Series | Prevention and management of diabetes-related foot disease
Scientific Statement | Hormones and aging
20 Jun, 2023 | 12:45h | UTCNews Release: Endocrine Society Scientific Statement distinguishes normal aging from endocrine disease – Endocrine Society
RCT | Testosterone replacement does not appear to increase cardiovascular events in hypogonadal men at high risk
19 Jun, 2023 | 14:13h | UTCCardiovascular Safety of Testosterone-Replacement Therapy – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary on Twitter
Presented today at #ENDO2023: In the TRAVERSE study, a randomized trial involving men with hypogonadism and preexisting or a risk of cardiovascular disease, testosterone therapy was noninferior to placebo with respect to major adverse cardiac events. https://t.co/V3FTTsOLd1
— NEJM (@NEJM) June 16, 2023
Review | Role of GLP1 receptor agonists in achieving weight loss and improving CV outcomes in people with overweight and obesity
19 Jun, 2023 | 13:40h | UTC
RCT | No significant kidney outcome differences observed across glucose-lowering medications in T2D patients
15 Jun, 2023 | 15:02h | UTCComparative Effects of Glucose-Lowering Medications on Kidney Outcomes in Type 2 Diabetes: The GRADE Randomized Clinical Trial – JAMA Internal Medicine (link to abstract – $ for full-text)
See also: Visual Abstract
Commentaries:
No differences found in effects of secondary diabetes drugs on kidney outcomes – ACP Diabetes
Do glucose-lowering medications have different effects on kidney outcomes? – News Medical
SR | Quality improvement strategies for diabetes care: Effects on outcomes for adults living with diabetes
15 Jun, 2023 | 14:57h | UTC
Cohort Study | Weight change and risk of obesity-related complications
15 Jun, 2023 | 14:53h | UTC
Commentary from the author on Twitter
Our paper showing association of weight loss on risk of developing 13 obesity-related complications
Weight loss benefit dependent on weight loss magnitude & initial BMI-weight gain associated with a similar risk ⬆️
4 patterns of association identifiedhttps://t.co/7iQCCsIJ3x pic.twitter.com/xVVLruS6Jg
— Prof Kamlesh Khunti (@kamleshkhunti) June 8, 2023
Consensus Statement | Use of liothyronine (T3) in hypothyroidism
13 Jun, 2023 | 13:46h | UTC
M-A | Elevated HbA1c in gestational diabetes mellitus tied to 1.7-fold rise in large for gestational age incidence
13 Jun, 2023 | 13:39h | UTC
M-A | Clinical outcomes associated with drugs for obesity and overweight
12 Jun, 2023 | 13:24h | UTC
Guideline Series | Prevention and management of diabetes-related foot disease
7 Jun, 2023 | 13:41h | UTCDefinitions and criteria for diabetes-related foot disease (IWGDF 2023 update)
Guidelines on the classification of foot ulcers in people with diabetes (IWGDF 2023 update)
Guidelines on offloading foot ulcers in persons with diabetes (IWGDF 2023 update)
RCT | Tirzepatide outperforms insulin glargine in HbA1c reduction and weight loss in type 2 diabetes
6 Jun, 2023 | 14:39h | UTC
Commentary on Twitter
The SURPASS-AP-Combo trial shows that addition of #tirzepatide as 2L or 3L therapy is non-inferior & superior to insulin glargine for glycemic outcomes at 40 weeks in an Asia-Pacific (mostly Chinese) population w/ type 2 #diabetes. https://t.co/RDh2WSJ1wZ pic.twitter.com/nm6pPpVdxH
— Nature Medicine (@NatureMedicine) June 2, 2023
Podcast | Insulin, type 2 diabetes, and hypoglycemia
6 Jun, 2023 | 14:25h | UTC#397: Insulin, Type 2 Diabetes, Fanny Packs, and Hypoglycemia with Dr. Jeff Colburn – The Curbsiders
Adrenal failure: an evidence-based diagnostic approach
6 Jun, 2023 | 14:16h | UTCAdrenal Failure: An Evidence-Based Diagnostic Approach – Diagnostics
M-A | Significant non-alcoholic fatty liver disease prevalence in South Asia, many non-obese affected
6 Jun, 2023 | 14:00h | UTC
Review | Subclinical hypothyroidism: let the evidence be your guide
2 Jun, 2023 | 12:08h | UTCSubclinical hypothyroidism: Let the evidence be your guide – Journal of Family Practice
Phase 2b RCT | Danuglipron, an oral GLP-1R agonist, reduces body weight and improves glycemic control in type 2 diabetes
1 Jun, 2023 | 12:17h | UTC
SR | Prevalence of clinical signs, symptoms and comorbidities at diagnosis of acromegaly
1 Jun, 2023 | 11:52h | UTC
M-A | Plant-based diets reduce key atherogenic lipoproteins
30 May, 2023 | 11:48h | UTCEditorial: Plant-based dietary patterns and atherogenic lipoproteins – European Heart Journal
Review | Child and adolescent obesity
30 May, 2023 | 11:45h | UTCChild and adolescent obesity – Nature Reviews Disease Primers (if the link is paywalled, try this one)
Commentary on Twitter
A Primer in @DiseasePrimers discusses the epidemiology, mechanisms, diagnosis, prevention and management of obesity in children and adolescents, highlighting patient quality of life and areas for further research. https://t.co/Zpcb4RbH2J pic.twitter.com/uneXxVyTDg
— Nature Portfolio (@NaturePortfolio) May 28, 2023
Review | Managing menopausal symptoms, fertility, and bone health in breast cancer women on endocrine therapy
30 May, 2023 | 11:40h | UTC